Press release
Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix
๐๐ก๐ ๐ซ๐๐๐๐ง๐ญ๐ฅ๐ฒ ๐ฉ๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐ ๐๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฏ๐๐๐ฅ๐ฌ ๐ญ๐ก๐๐ญ ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ง๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐๐% ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ง๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐จ๐๐๐๐ซ ๐๐ง ๐๐๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐จ๐ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐.
The need for neurological biomarkers has grown as a result of the growing existence of neurological illnesses involving conditions such as migraine, dementia, Alzheimer's disease, brain tumors, epilepsy, and others is confident of driving market augmentation. For instance, as per WHO, epilepsy causes roughly 13 million impairments calibrated life cycle and accounts for more than 0.5% of the global disease loads.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market/request-for-sample
Lately, biomarkers have been increasingly embraced in clinical patterns and clinical attempts in the area of neurology. The tempo of detection has been speeding due to technological progressions with escalated accuracy and susceptibility of the instrument and assays and cross-fertilization from one area of neurology to another. The weapons of biomarkers in neurology are prone to continue growing as the potential to estimate precisely manifold biological dynamics and knowhow about the pathophysiology of neurological illnesses escalate. They are utilized for many causes, to steer clinical diagnosis, to approximate illness probability or prognosis, to gauge illness phase, and to observe advancement or answer to therapy.
๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐
The market is portrayed by fierce contention, with entrenched players depending on progressive technology, elevated standard commodities, and a robust brand image to push revenue growth.
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ฐ๐ก๐ข๐๐ก ๐๐ซ๐ ๐๐ฎ๐ซ๐ซ๐๐ง๐ญ๐ฅ๐ฒ ๐๐จ๐ฆ๐ข๐ง๐๐ญ๐ข๐ง๐ ๐ญ๐ก๐ ๐ง๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐ซ๐:
โข Abbott
โข Alseres Pharmaceuticals, Inc.
โข BANYAN BIOMARKERS, INC.
โข Bio-Rad Laboratories, Inc.
โข DiaGenic ASA
โข Johnson & Johnson Services, Inc.
โข Merck & Co., Inc.
โข Myriad Genetics, Inc.
โข Quanterix
โข Thermo Fisher Scientific, Inc.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/2965/0
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ
โข The primary factors propelling the market growth of neurological biomarkers are blood-based biomarkers, playing an important part in choosing relevant remedies and observing disease advancement.
โข The neurological biomarkers market analysis is mainly based on type, application, end-use, and region.
โข North America dominated the market.
โข The market in Asia Pacific will increase as a result of the growth of clinical trials in surfacing nations such as China and India and a growing illness weight.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
๐๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐ข๐ฆ๐๐ซ๐ข๐ฅ๐ฒ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ญ๐ฒ๐ฉ๐, ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง, ๐๐ง๐-๐ฎ๐ฌ๐, ๐๐ง๐ ๐ซ๐๐ ๐ข๐จ๐ง.
๐๐ฒ ๐๐ฒ๐ฉ๐
โข Metabolomic
โข Genomic
โข Imaging
โข Proteomic
โข Others
๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง
โข Autism Spectrum Disorder
โข Parkinson's Disease
โข Alzheimer's Disease
โข Multiple Sclerosis
โข Others
๐๐ฒ ๐๐ง๐ ๐๐ฌ๐
โข Independent clinical diagnostic centers
โข Research Organizations and Others
โข Hospital & Hospital Laboratories
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐จ๐ฉ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
โข Offers a thorough analysis of neurological biomarkers market covering all the major aspects.
โข Provides an estimation of the current, historical, and projected market size in terms of volume and value.
โข Includes a detailed market segmentation covering all the major segments and sub-segments.
โข An examination of the top market trends and developments has been provided in the report.
โข Assesses the strategies of key market players and their product offerings.
โข The study analyzes the changing market dynamics and classifies new partners or clients in the target demographic.
๐๐ฅ๐ข๐๐ค ๐ก๐๐ซ๐ ๐ญ๐จ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market
๐๐๐ฒ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐๐ง๐ฌ๐ฐ๐๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
โข What is the current neurological biomarkers market size and forecast value?
โข Who are the key players in the market?
โข What are the opportunities and challenges market players might encounter?
โข What are the key trends driving the market growth?
โข At what CAGR is the market anticipated to grow?
โข What is the estimated demand for different types of products/services in the market?
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
๐๐ฑ๐ข๐๐๐ญ๐ข๐ฏ๐ ๐๐ญ๐ซ๐๐ฌ๐ฌ ๐๐ฌ๐ฌ๐๐ฒ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/oxidative-stress-assay-market
๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐ฒ๐ฌ๐ญ๐๐ฆ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/regulatory-information-management-system-market
๐.๐. ๐๐ข๐๐๐๐ญ๐๐ฌ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/us-diabetes-devices-market
๐๐ฅ๐ฅ๐๐ซ๐ ๐ฒ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/allergy-diagnostics-market
๐๐ฅ๐ฎ๐๐จ๐ฌ๐ ๐๐ข๐จ๐ฌ๐๐ง๐ฌ๐จ๐ซ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/glucose-biosensors-market
๐๐จ๐ง๐ญ๐๐๐ญ:
๐๐ข๐ค๐ก๐ข๐ฅ ๐
8 The Green Ste 19824,
Dover, DE 19901,
United States
๐๐ก๐จ๐ง๐:+1-929 297-9727
๐๐ฆ๐๐ข๐ฅ: sales@polarismarketresearch.com
๐๐๐: https://www.polarismarketresearch.com
๐ ๐จ๐ฅ๐ฅ๐จ๐ฐ ๐๐ฌ: LinkedIn | Twitter
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix here
News-ID: 3666777 • Views: โฆ
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Neurological
Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growthโฆ
Neurological Biomarkers Market : An Overview
Introduction:
Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans forโฆ
Neurological Biomarkers Market: An Overview
Introduction:
Neurological biomarkers refer to measurable indicators that can be used to detect or monitor neurological diseases or disorders. These biomarkers provide critical insights into the diagnosis, progression, and treatment of neurological conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neurological biomarkers are typically measured in bodily fluids like cerebrospinal fluid (CSF), blood, or even imaging techniques like MRI. With advancements in molecular biology, genomics, andโฆ
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder โฆ
๐๐ง๐ญ๐ซ๐จ๐๐ฎ๐๐ญ๐ข๐จ๐ง:
Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, andโฆ
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi โฆ
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,โฆ
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov โฆ
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview ofโฆ